Related references
Note: Only part of the references are listed.Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
Maria Parkhurst et al.
CLINICAL CANCER RESEARCH (2017)
T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
Else M. Inderberg et al.
ONCOIMMUNOLOGY (2017)
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy
Garnet Suck et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
A conserved αβ transmembrane interface forms the core of a compact T-cell receptor-CD3 structure within the membrane
Logesvaran Krshnan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
Steven C. Katz et al.
CLINICAL CANCER RESEARCH (2015)
Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
H. Almasbak et al.
GENE THERAPY (2015)
Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance
Douglas C. Palmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Unpredicted phenotypes of two mutants of the TcR DMF5
Fitsum G. Tadesse et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Soluble T-Cell Receptors Produced in Human Cells for Targeted Delivery
Even Walseng et al.
PLOS ONE (2015)
Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation
Sebastien Walchli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
Michael C. Jensen et al.
IMMUNOLOGICAL REVIEWS (2014)
TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity
Coen Govers et al.
JOURNAL OF IMMUNOLOGY (2014)
Molecular architecture of the αβ T cell receptor-CD3 complex
Michael E. Birnbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
Cor H. J. Lamers et al.
MOLECULAR THERAPY (2013)
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
James N. Kochenderfer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
Marcela V. Maus et al.
CANCER IMMUNOLOGY RESEARCH (2013)
T cells and their eons-old obsession with MHC
Lei Yin et al.
IMMUNOLOGICAL REVIEWS (2012)
How (specific) would you like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer
Inbal Daniel-Meshulam et al.
FRONTIERS IN IMMUNOLOGY (2012)
CD3 limits the efficacy of TCR gene therapy in vivo
Maryam Ahmadi et al.
BLOOD (2011)
Transiently redirected T cells for adoptive transfer
Hilde Almasbak et al.
CYTOTHERAPY (2011)
High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice
Jin Hee Kim et al.
PLOS ONE (2011)
A Practical Approach to T-Cell Receptor Cloning and Expression
Bastien Walchli et al.
PLOS ONE (2011)
Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors
David H. Aggen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Selected Murine Residues Endow Human TCR with Enhanced Tumor Recognition
Gil Bialer et al.
JOURNAL OF IMMUNOLOGY (2010)
Minimal Amino Acid Exchange in Human TCR Constant Regions Fosters Improved Function of TCR Gene-Modified T Cells
Daniel Sommermeyer et al.
JOURNAL OF IMMUNOLOGY (2010)
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
Gavin M. Bendle et al.
NATURE MEDICINE (2010)
Mixed T cell receptor dimers harbor potentially harmful neoreactivity
Marleen M. van Loenen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond
Cyrille J. Cohen et al.
CANCER RESEARCH (2007)
Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma
Julie R. Park et al.
MOLECULAR THERAPY (2007)
Facilitating matched pairing and expression of TCR chains introduced into human T cells
Jurgen Kuball et al.
BLOOD (2007)
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes
Laura A. Johnson et al.
JOURNAL OF IMMUNOLOGY (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region
MHM Heemskerk et al.
BLOOD (2003)
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
I Saeterdal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
